Europe Infusion Devices Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The Europe infusion devices market is projected to grow significantly, reaching approximately USD 6,590.36 million by 2031, up from USD 4,047.05 million in 2023, with a compound annual growth rate (CAGR) of 6.3% during this period.

Executive Summary and Market Analysis

The market is divided into several key regions, including Germany, the UK, France, Spain, Italy, and the Rest of Europe. The growth of the infusion devices market in Europe is primarily driven by the increasing use of infusion devices, particularly infusion pumps, for managing chronic conditions such as cancer, diabetes, and circulatory diseases. Additionally, strategic initiatives by companies, such as geographical expansion, are further propelling market growth. For example, in January 2024, Medtronic plc received CE Mark approval for its MiniMed 780G insulin pump system, which includes a disposable continuous glucose monitor (CGM), set to be released in Europe in the summer of 2024.

Market Segmentation Analysis

The Europe infusion devices market can be analyzed through various segments, including product type, application, and end user.

Product Type: The market is categorized into infusion pumps and infusion sets, with infusion pumps dominating the market share in 2023. Within infusion pumps, volumetric pumps, syringe pumps, insulin pumps, patient-controlled analgesia (PCA) pumps, enteral pumps, implantable pumps, and elastomeric pumps are included, with volumetric pumps holding the largest share. Infusion sets are further divided into vented and non-vented sets, with vented sets leading in market share.
Application: The market is segmented by application into diabetes, oncology, pain management, hematology, pediatrics, gastroenterology, and others, with diabetes being the largest segment in 2023.
End User: The end users of infusion devices include hospitals and specialty clinics, homecare settings, ambulatory surgical centers, and others, with hospitals and specialty clinics accounting for the largest share in 2023.

Market Outlook

The global increase in life expectancy is contributing to a growing geriatric population, which is expected to drive demand for infusion devices. According to the World Health Organization (WHO), by 2030, one in six people will be aged 60 or older, with the number of individuals aged 60 and above projected to rise from one billion in 2020 to 2.1 billion by 2050. Notably, Europe and Asia have the highest proportions of elderly populations, with countries like Japan and Italy leading in the percentage of seniors.

Infusion therapy offers several benefits for older adults, including:

Rehydration and Electrolyte Balance: Older adults are at a higher risk of dehydration, and infusion therapy can help maintain hydration and electrolyte levels.
Improved Nutritional Status: Infusion therapy can deliver essential nutrients directly into the bloodstream, aiding those who struggle with nutrient absorption due to age.
Enhanced Immune Function: Infusion therapy can provide immune-boosting nutrients, which are crucial for older adults who are more susceptible to infections.
Pain Management: Infusion therapy can effectively manage chronic pain by delivering medications directly into the bloodstream, improving the quality of life for seniors.

Country Insights

The market analysis by country reveals that Germany held the largest share in 2023. The prevalence of chronic diseases, particularly diabetes and cancer, is rising in Germany. According to the IDF Diabetes Atlas, the number of individuals with diabetes in Germany was 6.12 million in 2021, projected to increase to 6.5 million by 2030. The use of insulin pump therapy among children and adolescents has also seen significant growth, indicating a strong market potential for infusion devices in the country.

Company Profiles

Key players in the Europe infusion devices market include B Braun SE, Baxter International Inc, Becton Dickinson and Co, BPL Medical Technologies Pvt Ltd, CODAN US Corp, Eitan Medical Ltd, Elimedical Inc, Fresenius Kabi AG, ICU Medical Inc, KD Scientific Inc, Medtronic Plc, Moog Inc, Nipro Corp, Polymedicure, Tandem Diabetes Care Inc, Terumo Corp, and Zimed Healthcare Ltd. These companies are focusing on strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.

Product Code: BMIRE00032019

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Europe Infusion Devices Market Landscape

4.1 PEST Analysis

5. Europe Infusion Devices Market - Key Market Dynamics

5.1 Europe Infusion Devices Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Cancer
- 5.2.2 Growing Geriatric Population
5.3 Market Restraints
- 5.3.1 Frequent Product Recalls of Infusion Devices
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
- 5.5.1 Growing Technological Advancements
5.6 Impact of Drivers and Restraints:

6. Europe Infusion Devices Market - Analysis

6.1 Europe Infusion Devices Market Revenue (US$ Million), 2021-2031
6.2 Europe Infusion Devices Market Forecast Analysis

7. Europe Infusion Devices Market Analysis - by Product Type

7.1 Infusion Pumps
- 7.1.1 Overview
- 7.1.2 Infusion Pumps: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Infusion Sets
- 7.2.1 Overview
- 7.2.2 Infusion Sets: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Infusion Devices Market Analysis - by Application

8.1 Diabetes
- 8.1.1 Overview
- 8.1.2 Diabetes: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Oncology
- 8.2.1 Overview
- 8.2.2 Oncology: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Pain Management
- 8.3.1 Overview
- 8.3.2 Pain Management: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Hematology
- 8.4.1 Overview
- 8.4.2 Hematology: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Pediatrics
- 8.5.1 Overview
- 8.5.2 Pediatrics: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Gastroenterology
- 8.6.1 Overview
- 8.6.2 Gastroenterology: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Infusion Devices Market Analysis - by End User

9.1 Hospitals and Specialty Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Specialty Clinics: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Homecare Settings
- 9.2.1 Overview
- 9.2.2 Homecare Settings: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Ambulatory Surgical Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgical Centers: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Infusion Devices Market - Country Analysis

10.1 Europe
- 10.1.1 Europe Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 Europe Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 Germany: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 Germany: Europe Infusion Devices Market Share - by Product Type
    - 10.1.1.2.2 Germany: Europe Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.2.3 Germany: Europe Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.2.4 Germany: Europe Infusion Devices Market Share - by Application
    - 10.1.1.2.5 Germany: Europe Infusion Devices Market Share - by End User
  - 10.1.1.3 United Kingdom: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 United Kingdom: Europe Infusion Devices Market Share - by Product Type
    - 10.1.1.3.2 United Kingdom: Europe Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.3.3 United Kingdom: Europe Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.3.4 United Kingdom: Europe Infusion Devices Market Share - by Application
    - 10.1.1.3.5 United Kingdom: Europe Infusion Devices Market Share - by End User
  - 10.1.1.4 France: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 France: Europe Infusion Devices Market Share - by Product Type
    - 10.1.1.4.2 France: Europe Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.4.3 France: Europe Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.4.4 France: Europe Infusion Devices Market Share - by Application
    - 10.1.1.4.5 France: Europe Infusion Devices Market Share - by End User
  - 10.1.1.5 Italy: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.5.1 Italy: Europe Infusion Devices Market Share - by Product Type
    - 10.1.1.5.2 Italy: Europe Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.5.3 Italy: Europe Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.5.4 Italy: Europe Infusion Devices Market Share - by Application
    - 10.1.1.5.5 Italy: Europe Infusion Devices Market Share - by End User
  - 10.1.1.6 Spain: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.6.1 Spain: Europe Infusion Devices Market Share - by Product Type
    - 10.1.1.6.2 Spain: Europe Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.6.3 Spain: Europe Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.6.4 Spain: Europe Infusion Devices Market Share - by Application
    - 10.1.1.6.5 Spain: Europe Infusion Devices Market Share - by End User
  - 10.1.1.7 Rest of Europe: Europe Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.7.1 Rest of Europe: Europe Infusion Devices Market Share - by Product Type
    - 10.1.1.7.2 Rest of Europe: Europe Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.7.3 Rest of Europe: Europe Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.7.4 Rest of Europe: Europe Infusion Devices Market Share - by Application
    - 10.1.1.7.5 Rest of Europe: Europe Infusion Devices Market Share - by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Infusion Devices Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Becton Dickinson and Co
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Fresenius Kabi AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 B Braun SE
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 CODAN US Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Elimedical Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 ICU Medical Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 BPL Medical Technologies Pvt Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Nipro Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 KD Scientific Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Medtronic Plc
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Zimed Healthcare Ltd
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 Terumo Corp
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
12.14 Eitan Medical Ltd
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
12.15 Polymedicure
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Financial Overview
- 12.15.4 SWOT Analysis
- 12.15.5 Key Developments
12.16 Moog Inc
- 12.16.1 Key Facts
- 12.16.2 Business Description
- 12.16.3 Products and Services
- 12.16.4 Financial Overview
- 12.16.5 SWOT Analysis
- 12.16.6 Key Developments
12.17 Tandem Diabetes Care Inc
- 12.17.1 Key Facts
- 12.17.2 Business Description
- 12.17.3 Products and Services
- 12.17.4 Financial Overview
- 12.17.5 SWOT Analysis
- 12.17.6 Key Developments

13. Appendix

13.1 About The Insight Partners